We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases.
- Authors
Kuruvilla, Joshua; Sasmita, Andrew Octavian; Ling, Anna Pick Kiong
- Abstract
<bold>Background and Purpose: </bold>The central nervous system (CNS) faces unique difficulties in attaining permanent therapy for neurodegenerative disorder (ND). Genomic level forms of therapy have garnered interest in the recent decade, with the novel CRISPR/Cas9 gene editing tool continuing to be explored due to its efficiency, safety, and adaptability to varying conditions. With the aid of viral vectors as transport vectors, the gene editing tool has produced promising in vitro and in vivo findings in study models. Thus, this review focuses on the recent advancements and update of CRISPR/Cas9 to combat neurodegenerative diseases.<bold>Methods: </bold>Articles detailing potential applications of CRISPR/Cas9 in neurodegenerative settings were retrieved from PubMed and Google Scholar with the keywords "CRISPR," "gene editing," and "neurodegenerative diseases." Relevant information was collected and critically reviewed.<bold>Results: </bold>The utility of CRISPR/Cas9 coupled with viral transduction ranges from the disruption of amyloid precursor protein (APP) production at a genomic level in Alzheimer's disease (AD) to the deletion of varying exon portions of the Dmd gene in Duchenne muscular dystrophy (DMD) which would increase dystrophin expression. This usage of CRISPR/Cas9 also extends to experimentally ameliorate the neurodegenerative effects caused by viral infections.<bold>Conclusion: </bold>The CRISPR/Cas9 gene editing tool is a powerful arsenal in the field of gene therapy and molecular medicine; hence, more research should be called to focus on the ample potential this tool has to offer in the field of neurodegenerative diseases.
- Subjects
NEURODEGENERATION; GENE therapy; CRISPRS; GENOME editing; AMYLOID beta-protein precursor; DUCHENNE muscular dystrophy; DYSTROPHIN genetics
- Publication
Neurological Sciences, 2018, Vol 39, Issue 11, p1827
- ISSN
1590-1874
- Publication type
journal article
- DOI
10.1007/s10072-018-3521-0